Mutual Fund Series Trust · net assets $1.79B · 93 holdings as of June 30, 2026. Monthly N-PORT disclosure: the full book, not just equities.
EC: 93.3% · STIV: 5.1% · EP: 1.4% · DO: 0.2% · DBT: 0.0%
| Month 1 | Month 2 | Month 3 | |
|---|---|---|---|
| Sales | $21.4M | $19.4M | $61.7M |
| Reinvestment | $0 | $0 | $0 |
| Redemptions | $45.6M | $48.8M | $78M |
| Net realized gain (non-derivative) | $12.7M | $-2.47M | $-1.67M |
| Net unrealized appreciation (non-derivative) | $72.8M | $5.16M | $192M |
The three months of the reporting period, as filed; month 3 ends June 30, 2026.
| Holding | Value | % of net assets |
|---|---|---|
| Guardant Health Inc EC | $96.1M | 5.37% |
| Us Bank Mmda STIV | $67M | 3.75% |
| Mirum Pharmaceuticals Inc EC | $62.1M | 3.47% |
| Kymera Therapeutics Inc EC | $57.7M | 3.22% |
| Abivax Sa EC | $52.6M | 2.94% |
| Belite Bio Inc EC | $50.6M | 2.83% |
| Trevi Therapeutics Inc EC | $49.6M | 2.77% |
| Mbx Biosciences Inc EC | $48.2M | 2.70% |
| Vaxcyte Inc EC | $48.1M | 2.69% |
| Cytokinetics Inc EC | $48M | 2.69% |
| Argenx Se EC | $45.6M | 2.55% |
| Ionis Pharmaceuticals Inc EC | $45.6M | 2.55% |
| Insmed Inc EC | $43M | 2.40% |
| Revolution Medicines Inc EC | $42.2M | 2.36% |
| Avalyn Pharma Inc EC | $42M | 2.35% |
| Immix Biopharma Inc EC | $40.1M | 2.24% |
| Celldex Therapeutics Inc EC | $38.6M | 2.16% |
| Palvella Therapeutics Inc EC | $35.4M | 1.98% |
| Kestra Medical Technologies Ltd EC | $34.8M | 1.95% |
| Scholar Rock Holding Corp EC | $34.8M | 1.95% |
| Apogee Therapeutics Inc EC | $34.5M | 1.93% |
| Definium Therapeutics Inc EC | $33.4M | 1.87% |
| Irhythm Holdings Inc EC | $33M | 1.85% |
| Bridgebio Pharma Inc EC | $32.6M | 1.82% |
| Beta Bionics Inc EC | $32.2M | 1.80% |
| Nurix Therapeutics Inc EC | $31.5M | 1.76% |
| Arrowhead Pharmaceuticals Inc EC | $30.2M | 1.69% |
| Disc Medicine Inc EC | $28.9M | 1.62% |
| Ovid Therapeutics Inc EC | $26.6M | 1.49% |
| Cg Oncology Inc EC | $26M | 1.46% |
| Amylyx Pharmaceuticals Inc EC | $23.8M | 1.33% |
| Oruka Therapeutics Inc EC | $22.8M | 1.28% |
| First American Funds Inc STIV | $22.4M | 1.25% |
| Dianthus Therapeutics Inc EC | $22M | 1.23% |
| Sionna Therapeutics Inc EC | $20.9M | 1.17% |
| Celcuity Inc EC | $20.5M | 1.14% |
| Glaukos Corp EC | $19.9M | 1.11% |
| Sutro Biopharma Inc EC | $19.4M | 1.09% |
| Privia Health Group Inc EC | $19M | 1.06% |
| Eyepoint Inc EC | $17.8M | 1.00% |
| Spyre Therapeutics Inc EC | $17.8M | 0.99% |
| Heartflow Inc EC | $17.5M | 0.98% |
| Dexcom Inc EC | $17M | 0.95% |
| Aktis Oncology Inc EC | $16.3M | 0.91% |
| Achieve Life Sciences Inc EC | $14.5M | 0.81% |
| United Therapeutics Corp EC | $14.4M | 0.80% |
| Undisclosed EC | $14.2M | 0.80% |
| Axsome Therapeutics Inc EC | $13.7M | 0.77% |
| Kailera Therapeutics Inc EC | $13.6M | 0.76% |
| Praxis Precision Medicines Inc EC | $12.8M | 0.72% |
| Tango Therapeutics Inc EC | $12.5M | 0.70% |
| Evommune Inc EC | $12.5M | 0.70% |
| Kardium Inc. EP | $10.8M | 0.60% |
| Oric Pharmaceuticals Inc EC | $10.3M | 0.58% |
| Belite Bio Inc EC | $9.58M | 0.54% |
| Bright Minds Biosciences Inc EC | $9.13M | 0.51% |
| Adlai Nortye Ltd EC | $8.27M | 0.46% |
| Kardigan Inc EC | $7.16M | 0.40% |
| Relmada Therapeutics Inc EC | $7.03M | 0.39% |
| Adlai Nortye Ltd EC | $6.51M | 0.36% |
Showing top 60 of 93 holdings.
Loading...
